Mode
Text Size
Log in / Sign up
N/A Completed N=32 Treatment

PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System

Critical Limb Ischemia · Chronic Limb-Threatening Ischemia
Source: ClinicalTrials.gov NCT03124875 ↗
Enrolled (actual)
32
Serious AEs
59.4%
Results posted
May 2024
Primary outcomePrimary: Amputation-free Survival — 90.6 Percentage of participants

Summary

This pilot study will investigate the safety, effectiveness and feasibility of the LimFlow Stent Graft System for creating an AV fistula in the Below The Knee (BTK) vascular system using an endovascular, minimally invasive approach for the treatment of Critical Limb Ischemia (CLI) in subjects ineligible for conventional endovascular or surgical limb salvage procedures.

Outcome Measures

OutcomeResultp-value
PRIMARY
Amputation-free Survival
73.8
SECONDARY
Amputation-free Survival
73.8
SECONDARY
Primary Patency
29.3
SECONDARY
Secondary Patency
49.5
SECONDARY
Limb Salvage
75.9
SECONDARY
Wound Healing
58.7
SECONDARY
Deterioration in Renal Function
9.4
SECONDARY
Technical Success
96.9
SECONDARY
Procedural Success
77.4

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of critical limb ischemia with hemodynamic evidence of severely diminished arterial inflow of the index limb and Rutherford Classification 5 r 6
  • Reviewed and approved for eligibility by the Investigator and the Independent Safety Committee (ISC)

Exclusion Criteria

  • Concomitant hepatic or renal insufficiency, thrombophlebitis, deep venous thrombus, coagulation disorder
  • Severe heart failure, recent MI or stroke
  • Significant peripheral edema or infection that may preclude insertion of a prosthesis or significantly impair wound healing
  • Known allergies or contraindications to anti platelet therapy or device materials
  • Immunodeficiency disorder or immunosuppressant therapy
  • Life expectancy < 12 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03124875). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search